CAMBRIDGE, Mass., Dec. 20 /PRNewswire-FirstCall/ -- Biopure
Corporation's (Nasdaq: BPUR) Board of Directors has approved the
appointment of David A. Butler as interim Chief Financial Officer.
Mr. Butler most recently served as Vice President, Finance and
Administration at the Millard Group, Inc., a services & consulting company.
Prior to that position, he served as Vice President, Finance, Chief
Financial Officer and Treasurer at Circe Biomedical, Inc., a
development-stage medical device manufacturer, formerly in Lexington, Mass.
Francis H. Murphy, the company's former CFO, retired on December 14,
2007 and has entered into a consulting agreement with the company for a
six-month term.
Biopure Corporation
Biopure Corporation develops, manufactures and markets pharmaceuticals,
called oxygen therapeutics, that are intravenously administered to deliver
oxygen to the body's tissues. Hemopure(R) [hemoglobin glutamer - 250
(bovine)], or HBOC-201, is approved for sale in South Africa for the
treatment of surgical patients who are acutely anemic. Biopure has applied
in the United Kingdom for regulatory approval of a proposed orthopedic
surgical anemia indication. The company is developing Hemopure for several
other indications and is supporting the U.S. Navy's government-funded
efforts to develop a potential out-of-hospital trauma indication. Biopure's
veterinary product Oxyglobin(R) [hemoglobin glutamer - 200 bovine)], or
HBOC-301, the only oxygen therapeutic approved by both the U.S. Food and
Drug Administration and the European Commission, is indicated for the
treatment of anemia in dogs. Biopure has sold approximately 186,000 units
of Oxyglobin.
Contact: Tiana Gorham Herb Lanzet (Investors)
Biopure Corporation H.L. Lanzet Inc.
(617) 234-6826 (212) 888-4570
IR@biopure.com lanzet@aol.com
SOURCE Biopure Corporation
 back to top
Related links:
http://www.biopure.com/
http://www.prnewswire.com/comp/131224.html/
CONTACT:
Tiana Gorham of Biopure Corporation,
+1-617-234-6826, IR@biopure.com; or Investors, Herb Lanzet of
H.L. Lanzet Inc., +1-212-888-4570, lanzet@aol.com, for Biopure
Corporation
|
